Skip to main content
$7.60 $0.16 (2.2%)

04:00 PM EDT on 10/03/23

AngioDynamics, Inc. (NASDAQ:ANGO)

CAPS Rating: No stars

The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.

Current Price $7.60 Mkt Cap $298.9M
Open $7.38 P/E Ratio -5.72
Prev. Close $7.60 Div. (Yield) $0.00 (0.0%)
Daily Range $7.37 - $7.64 Volume 459,183
52-Wk Range $6.72 - $21.80 Avg. Daily Vol. 674,194

Caps

How do you think NASDAQ:ANGO will perform against the market?

Add Stock to CAPS Watchlist

All Players

105 Outperform
13 Underperform
 

All-Star Players

25 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ANGO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (39.74)
Submitted October 28, 2021

AngioDynamics is forecasting that it will nearly triple its total addressable market from $3 billion last fiscal year to $8 billion by FY25. AngioDynamics also has a $10.5 million net cash position to support its growth ambitions. And the stock… More

diefendb (< 20)
Submitted March 14, 2007

I expect them to take a hit in litigation vs. Diomed.

Recent Community Commentary

Read the most recent pitches from players about ANGO.

Recs

1
Member Avatar TMFkodyk123 (39.74) Submitted: 10/28/2021 4:41:40 PM : Outperform Start Price: $28.30 NASDAQ:ANGO Score: -65.63

AngioDynamics is forecasting that it will nearly triple its total addressable market from $3 billion last fiscal year to $8 billion by FY25. AngioDynamics also has a $10.5 million net cash position to support its growth ambitions. And the stock trades at just 3.5 times this year's sales forecast, which is a good value considering its high-single-digit annual sales growth potential.

Recs

0
Member Avatar WilliamCrook2003 (71.13) Submitted: 11/15/2013 3:43:56 AM : Outperform Start Price: $15.56 NASDAQ:ANGO Score: -185.95

MF Stock of the day.

Recs

5
Member Avatar KatWoman50 (40.76) Submitted: 3/7/2008 9:11:31 PM : Outperform Start Price: $10.05 NASDAQ:ANGO Score: -262.85

Provider of medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease.
Acquired RITA in 2007 and now has a diverse product line that includes radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
Advance guidence on 3Q sales growth of 14% missed wallstreets expectations and sent the stock down 37% for the day. BUY BUY BUY

Leaderboard

Find the members with the highest scoring picks in ANGO.

Score Leader

diefendb

diefendb (< 20) Score: +287.31

The Score Leader is the player with the highest score across all their picks in ANGO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
diefendb < 20 3/7/2007 Underperform 1Y $22.86 -66.75% +220.56% +287.31 1 Comment
avatarslayer < 20 3/28/2007 Underperform 3W $19.71 -61.44% +213.56% +275.00 0 Comment
kick6run2 < 20 7/18/2011 Underperform 1Y $15.43 -50.75% +221.63% +272.37 0 Comment
devildoc8404 30.47 6/4/2008 Underperform 1Y $15.60 -51.28% +217.09% +268.37 0 Comment
megatraders 90.30 3/10/2008 Underperform 3W $10.05 -24.38% +238.47% +262.85 0 Comment
MarketBottom 27.41 4/4/2008 Underperform 3M $12.80 -40.62% +217.30% +257.93 0 Comment
3waystopsign < 20 3/12/2008 Underperform 3W $10.20 -25.49% +230.56% +256.05 0 Comment
e2nelson < 20 4/20/2007 11/14/2008 Underperform 1Y $16.16 -52.97% +200.70% +253.67 1 Comment
anniejan 51.63 10/1/2007 Underperform 1Y $19.68 -61.38% +189.44% +250.82 0 Comment
MRTShorts 96.10 10/8/2007 Underperform NS $20.57 -63.05% +184.26% +247.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ANGO.